Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (5730)	10/6/1998 8:03:00 PM
From: Rocketman	Read Replies (1) \| Respond to of 9719

Covering the ENMD short WAS a good idea back then, but since it was shorted at $34+, it is still well in the money. This stock is so hype prone and driven by emotionally challenged alleged investors that I expect it to continue to be volatile. You still have "investors" that bought this in the $50-$80 range who are convinced that the cancer cure will be out next year. I think the grandmas and pensioneers are going to be waiting a long long time before ever seeing any profits or being convinced to take their losses. Reality is a tough tutor. I'd consider shorting it if it got into the $30's again, but am hesitant to pre-order shorts due to the unlimited downside potential. I mean if I put in an order to short at $30 and it goes to $40 before crashing back (which it would for sure), I'd bum out on all of the lost profits. Plus shorts make V1 nervous and triggerprone @;-> Rman